Donor activating KIR genes significantly influence relapse in leukemia patients after myeloablative conditioning followed by in-vivo T-CELL depleted [ATG] unrelated stem cell transplantation

被引：0
|
作者：
Kroeger, Nicolaus [1 ]
Binder, Thomas [1 ]
Zabelina, Tatjana [1 ]
Schieder, Heike [1 ]
Renges, Helmut [1 ]
Ayuk, Francis [1 ]
Wolschke, Christine [1 ]
Eiermann, Thomas [1 ]
Zander, Axel R. [1 ]
机构：
[1] Univ Med Ctr Hamburg Eppendorf, Transplant Ctr, Dept Bone Marrow Transplant, Hamburg, Germany
来源：
ANNALS OF HEMATOLOGY | 2006年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：26 / 27
页数：2
相关论文
共 50 条
  • [21] Impact of CD 34 Cell Dose and Conditioning Regimens on Donor T-Cell and Myeloid Chimerism After an Alemtuzumab-Based in-Vivo T-Cell Depleted Allogeneic Stem Cell Transplant (SCT)
    Fung, Henry C.
    Maciejewski, John
    Buckingham, Lela
    Alikhan, Muhammed
    Melinamani, Shruthi
    Karmali, Reem
    Rich, Elizabeth
    Venugopal, Parameswaran
    Gregory, Stephanie A.
    Nathan, Sunita
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S289 - S289
  • [22] Prevention of relapse by donor lymphocyte infusion for mixed chimerism 7 months after T-cell depleted allogeneic stem cell transplantation
    Marijt, W.
    Baas, I.
    von dem Borne, P.
    Barge, R.
    Deutz, P.
    Beaumont, F.
    Starrenburg, I.
    Fibbe, W.
    Willemze, R.
    Falkenburg, J.
    [J]. BONE MARROW TRANSPLANTATION, 2008, 41 : S161 - S161
  • [23] Beyond HLA - donor KIR haplotype A is associated with improved disease-free and overall survival after in vivo T-cell depleted allogeneic haematopoietic stem-cell transplantation from unrelated donors
    Eiermann, T. H.
    Binder, T.
    Alster, I.
    Zabelina, E.
    Zander, A. R.
    Kroeger, N.
    [J]. TISSUE ANTIGENS, 2007, 69 (05): : 385 - 386
  • [24] Reduced-intensity conditioning regimen with ex vivo T-cell depletion after unrelated donor as stem cell source for patients with haematological malignancies
    Castagna, L.
    Crocchiolo, R.
    Furst, S.
    El Cheikh, J.
    Esterni, B.
    Granata, A.
    Lemarie, C.
    Oudin, C.
    Faucher, C.
    Chabannon, C.
    Blaise, D.
    [J]. BONE MARROW TRANSPLANTATION, 2011, 46 : S329 - S329
  • [25] Patterns of Late Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with T-Cell Prolymphocytic Leukemia
    Shumilov, Evgenii
    Hasenkamp, Justin
    Szuszies, Christoph Johannes
    Koch, Raphael
    Wulf, Gerald Georg
    [J]. ACTA HAEMATOLOGICA, 2021, 144 (01) : 105 - 110
  • [26] Influence of donor KIR genotypes on reduced relapse risk in acute myelogenous leukemia after hematopoietic stem cell transplantation in patients with CMV reactivation
    Nakamura, Ryotaro
    Gendzekhadze, Ketevan
    Palmer, Joycelynne
    Tsai, Ni-Chun
    Mokhtari, Sally
    Forman, Stephen J.
    Zaia, John A.
    Senitzer, David
    Marcucci, Guido
    Stein, Anthony
    [J]. LEUKEMIA RESEARCH, 2019, 87
  • [27] Development of an Alpha/Beta T-Cell Depleted Allogeneic Stem Cell Transplantation Protocol Form Matched Related and Unrelated Donor Grafts in Patients with Poor Risk Leukemia
    DeWitte, Moniek A.
    te Boome, Liane
    van der Wagen, Lotte
    Kuball, Jurgen H.
    [J]. BLOOD, 2014, 124 (21)
  • [28] DEVELOPMENT OF AN ALPHA/BETA T-CELL DEPLETED ALLOGENEIC STEM CELL TRANSPLANTATION PROTOCOL FROM MATCHED RELATED AND UNRELATED DONOR GRAFTS IN PATIENTS WITH POOR RISK LEUKEMIA
    de Witte, M.
    te Boome, L.
    van der Wagen, L.
    Westinga, K.
    Slaper-Cortenbach, I.
    Kuball, J.
    [J]. HAEMATOLOGICA, 2014, 99 : 421 - 421
  • [29] In vitro and in vivo T-cell depletion with myeloablative or reduced-intensity conditioning in pediatric hematopoietic stem cell transplantation
    Seidel, Markus G.
    Fritsch, Gerhard
    Matthes-Martin, Susanne
    Lawitschka, Anita
    Lion, Thomas
    Poetschger, Ulrike
    Rosenmayr, Agathe
    Fischer, Gottfried
    Gadner, Helmut
    Peters, Christina
    [J]. HAEMATOLOGICA, 2005, 90 (10) : 1405 - 1414
  • [30] Unrelated donor hematopoietic stem cell (HSC) transplantation after administration of a non-myeloablative conditioning regimen.
    Rowley, SD
    Goldberg, SL
    Pecora, AL
    Rosenbluth, RJ
    [J]. BLOOD, 2001, 98 (11) : 387B - 387B
12345